Revamp at Silence does little to improve investors wellbeing

Revamp at Silence does little to improve investors’ wellbeing

Biotech group has changed management team and reviewed its corporate strategy

Original Article: Revamp at Silence does little to improve investors’ wellbeing

More From BioPortfolio on "Revamp at Silence does little to improve investors’ wellbeing"